News & Insights

SolentimNews & Insights
Corporate, Product sciadseo

Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco

Bournemouth, UK, 7th October 2020 / Solentim is pleased to announce the adoption of its VIPS™ single cell seeding platform and Cell Metric® CLD into Samsung Biologics’ new research and development facility in San Francisco, CA. These instruments are designed for single cell cloning and assurance of monoclonality to increase the speed and efficiency of Master Cell Bank development. Samsung’s new R&D …

Read more Solentim to supply cell line development solutions for Samsung Biologics’ new R&D center in San Francisco

Corporate, Product sciadseo

Solentim launches new workflow for single cell cloning of stem cells

VIPS™ + MatriClone™ combination ensures high efficiency seeding of hiPSCs with high viability Solentim, the global leader for solutions to create, isolate and characterize the highest value cells for the development of new biological medicines, yesterday launched a dedicated new workflow for single cell cloning of human induced pluripotent stem cells (hiPSCs). A combination of Solentim’s VIPS™ (verified in-situ plate seeding) instrument …

Read more Solentim launches new workflow for single cell cloning of stem cells

Conferences sciadseo

Solentim will present at Cell Series UK Virtual, the 9th Annual Cell Culture and Bioprocessing Conference

Solentim, the global leader for solutions to create, isolate and characterize the highest value cells for the development of new biological medicines, is pleased to present at Oxford Global’s 9th Annual Cell Culture and Bioprocessing Virtual Conference on the 6-7th October 2020. Dr Ian Taylor, Chief Business Officer at Solentim, will be speaking on Day 1 (6th October 2020), …

Read more Solentim will present at Cell Series UK Virtual, the 9th Annual Cell Culture and Bioprocessing Conference

Conferences sciadseo

Join Solentim online at BioProcess International US, 21-25 September 2020

We are delighted to announce that Solentim will join the global bioprocessing community at BioProcess International US (BPI US) on the 21-25 September 2020, an entirely virtual conference and exhibition, as part of Biotech Week Boston. Mark Stockdale, Amalgamator of Business and Biology at Solentim, will present ‘Building a high confidence image-based clonality workflow. Is 99% …

Read more Join Solentim online at BioProcess International US, 21-25 September 2020

Corporate sciadseo

Australian Institute for Bioengineering and Nanotechnology adopts Solentim Cell Metric for rapid vaccine program

The Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland has adopted the market-leading Cell Metric® whole well imaging system from Solentim to support its Rapid Response Vaccine Pipeline. The UQ team was funded by Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership launched in 2017 to develop vaccines to stop …

Read more Australian Institute for Bioengineering and Nanotechnology adopts Solentim Cell Metric for rapid vaccine program

Corporate sciadseo

Continued growth and progress for Solentim: 2019/2020 highlights

Solentim, the world leader in instruments and workflow solutions to create, isolate and characterize the highest value cells for the development of new biological medicines and therapies reports another record year for the 12 months to June 2020. Solentim has achieved record revenue growth from instrument sales and service support, with particular strength in the …

Read more Continued growth and progress for Solentim: 2019/2020 highlights